Home/Filings/4/0001104659-19-033437
4//SEC Filing

Van der Ploeg Leonardus H.T. 4

Accession 0001104659-19-033437

CIK 0001649904other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:00 PM ET

Size

14.4 KB

Accession

0001104659-19-033437

Insider Transaction Report

Form 4
Period: 2019-05-30
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-05-31+5,0008,611 total
    Exercise: $4.59Exp: 2025-11-16Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2019-05-31$4.59/sh+5,000$22,95047,339 total
  • Sale

    Common Stock

    2019-05-31$25.10/sh5,000$125,50042,339 total
  • Exercise/Conversion

    Common Stock

    2019-05-30$4.59/sh+5,000$22,95047,339 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-05-30+5,00013,611 total
    Exercise: $4.59Exp: 2025-11-16Common Stock (5,000 underlying)
  • Sale

    Common Stock

    2019-05-30$25.31/sh5,000$126,55042,339 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $25.11 to $25.64, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $25.00 to $25.33, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.

Documents

1 file

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1
  • filerCIK 0001615726

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:00 PM ET
Size
14.4 KB